Effects of inhaled hypertonic (7%) saline on lung function test in preschool children with cystic fibrosis: results of a crossover, randomized clinical trial.
Open Access
- 15 July 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in Italian Journal of Pediatrics
- Vol. 43 (1), 60
- https://doi.org/10.1186/s13052-017-0376-6
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Inhaled Hypertonic Saline in Infants and Children Younger Than 6 Years With Cystic FibrosisJAMA, 2012
- Hypertonic Saline in Treatment of Pulmonary Disease in Cystic FibrosisThe Scientific World Journal, 2012
- Reference ranges for interrupter resistance technique: the Asthma UK InitiativeEuropean Respiratory Journal, 2009
- Nebulised hypertonic saline for cystic fibrosisEmergencias, 2009
- Safety and tolerability of inhaled hypertonic saline in young children with cystic fibrosisPediatric Pulmonology, 2008
- Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosisPediatric Pulmonology, 2007
- The interrupter technique to assess airway responsiveness in children with cystic fibrosisPediatric Pulmonology, 2006
- Airway Resistance Measurements in Children with Cystic FibrosisPhysiotherapy, 2003
- Measurement of lung function in preschool children using the interrupter techniqueThorax, 2003
- Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosisThorax, 2002